• Info
  • Insider Ownership

Insider Trading & Ownership of Brendan Smith

Location
Lexington, MA
Summary
The estimated net worth of Brendan Smith is at least $317,015 dollars as of 22 Feb 2023. Brendan Smith is the Chief Financial Officer of CRISPR Therapeutics AG and owns shares of CRISPR Therapeutics AG (CRSP) stock worth about $317K.
Signature
/s/ Elizabeth Ryland Waldinger, attorney-in-fact
All Insider Reports
All Insider Reports

Notify me when Brendan Smith files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Brendan Smith

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
CRSP CRISPR Therapeutics AG Chief Financial Officer $317,015 18 Feb 2023
TBIO Translate Bio, Inc. Chief Financial Officer 14 Sep 2021

Insider Transactions Reported by Brendan Smith:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.